rupatadine has been researched along with Hay Fever in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Jiang, P; Liu, Y; Shi, J; Zhang, W | 1 |
| Aoki, H; Okubo, K; Suzuki, T; Tanaka, A | 1 |
| Canonica, GW; Compalati, E | 1 |
| Berger, VW; Gudehithlu, SK | 1 |
| Katiyar, S; Prakash, S | 1 |
| Bartrá, J; Izquierdo, I; Mullol, J; Muñoz-Cano, R; Picado, C; Serrano, C; Valero, A | 1 |
| Allala, U; Jaida, J; Maiti, R; Palani, A; Rahman, J | 1 |
| Maurer, M; Metz, M | 1 |
| Bartra, J; del Cuvillo, A; Giralt, J; Izquierdo, I; Mullol, J; Valero, A | 1 |
| Baillieau, RA; Barkai, L; Doménech, A; Garde, JM; Giralt, J; Izquierdo, I; Maspero, JF; Németh, I; Nieto, A; Potter, P; Vermeulen, J | 1 |
| García-Rafanell, J; Izquierdo, I; Merlos, M | 1 |
| Dumur, JP; Izquierdo, I; Pérez, I; Saint-Martin, F | 1 |
| Castillo, JA; De Molina, M; Guadaño, EM; Meseguer, J; Picado, C; Serra-Batlles, J; Valero, A | 1 |
| Arnaiz, E; Borja, J; Conde, J; De Molina, M; Izquierdo, I; Martí-Guadaño, E; Martínez-Cócera, C; Pérez, I; Pola, J | 1 |
| Arnáiz, E; Horak, F; Izquierdo, I; Leuratti, C; Pérez, I; Stuebner, P; Zieglmayer, R | 1 |
| Picado, C | 1 |
| Keam, SJ; Plosker, GL | 1 |
| Bachert, C; Bousquet, J; Canonica, WG; Gimenez-Arnau, A; Kowalski, ML; Martí-Guadaño, E; Maurer, M; Mullol, J; Picado, C; Scadding, G; Van Cauwenberge, P | 1 |
7 review(s) available for rupatadine and Hay Fever
| Article | Year |
|---|---|
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2013 |
Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis.
Topics: Adolescent; Adult; Cyproheptadine; Histamine H1 Antagonists, Non-Sedating; Humans; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Young Adult | 2009 |
Rupatadine for the treatment of allergic rhinitis and urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2011 |
Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis.
Topics: Animals; Clinical Trials as Topic; Cyproheptadine; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2003 |
Rupatadine: pharmacological profile and its use in the treatment of allergic disorders.
Topics: Adolescent; Adult; Animals; Cyproheptadine; Histamine H1 Antagonists; Humans; Psychomotor Performance; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria | 2006 |
Rupatadine: a review of its use in the management of allergic disorders.
Topics: Adolescent; Adult; Aged; Animals; Anti-Allergic Agents; Cyproheptadine; Drug Interactions; Humans; Hypersensitivity; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria | 2007 |
Rupatadine in allergic rhinitis and chronic urticaria.
Topics: Adolescent; Animals; Anti-Allergic Agents; Child; Chronic Disease; Clinical Trials as Topic; Cyproheptadine; Dogs; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2008 |
9 trial(s) available for rupatadine and Hay Fever
| Article | Year |
|---|---|
Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Anti-Allergic Agents; Child; Cyproheptadine; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Rhinitis, Allergic, Seasonal; Treatment Outcome; Young Adult | 2019 |
Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
Topics: Administration, Intranasal; Adolescent; Adult; Anti-Allergic Agents; Cyproheptadine; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nasal Cavity; Nasal Obstruction; Pruritus; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinometry, Acoustic; Treatment Outcome | 2009 |
Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
Topics: Adolescent; Adult; Cetirizine; Conjunctivitis, Allergic; Cyproheptadine; Eosinophils; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Immunoglobulin E; Leukocyte Count; Male; Quality of Life; Rhinitis, Allergic, Seasonal; Single-Blind Method; Young Adult | 2010 |
Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients.
Topics: Administration, Intranasal; Adrenal Cortex Hormones; Adult; Cyproheptadine; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Longitudinal Studies; Male; Nose; Prospective Studies; Quality of Life; Rhinitis, Allergic, Seasonal | 2011 |
Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Analysis of Variance; Anti-Allergic Agents; Argentina; Child; Cyproheptadine; Double-Blind Method; Europe; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Quality of Life; Rhinitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; South Africa; Time Factors; Treatment Outcome | 2013 |
A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Child; Cross-Over Studies; Cyproheptadine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Platelet Activating Factor; Probability; Reference Values; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Treatment Outcome | 2004 |
Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Allergic Agents; Butyrophenones; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Piperidines; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Treatment Outcome | 2004 |
Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Cyproheptadine; Double-Blind Method; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2005 |
Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.
Topics: Adolescent; Adult; Antigens, Plant; Cross-Over Studies; Cyproheptadine; Dactylis; Double-Blind Method; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Inhalation Exposure; Male; Middle Aged; Nasal Mucosa; Placebos; Pollen; Rhinitis, Allergic, Seasonal; Sneezing | 2006 |
2 other study(ies) available for rupatadine and Hay Fever
| Article | Year |
|---|---|
Efficacy and Safety of Rupatadine Fumarate Combined with Acupoint Application in Allergic Rhinitis Complicated with Diabetes.
Topics: Acupuncture Points; Cyproheptadine; Diabetes Mellitus; Fumarates; Humans; Immunoglobulin E; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal | 2022 |
Re: Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Letter to the editor.
Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal | 2013 |